Symbol:
Agbl2
Name:
AGBL carboxypeptidase 2
RGD ID:
1306827
Description:
Predicted to enable metallocarboxypeptidase activity and tubulin binding activity. Predicted to be involved in protein side chain deglutamylation. Predicted to be located in ciliary basal body and cytosol. Predicted to be active in centriole and cytoplasm. Orthologous to human AGBL2 (AGBL carboxypeptidase 2); INTERACTS WITH alpha-Zearalanol; bisphenol A; endosulfan.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
ATP/GTP binding protein-like 2; cytosolic carboxypeptidase 2; cytosolic carboxypeptidase 2-like; LOC103690183; LOC366124; RGD1306827; similar to CG32627-PB
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 97,220,654 - 97,255,905 (+) NCBI GRCr8 mRatBN7.2 3 76,764,893 - 76,800,071 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 76,764,238 - 76,800,214 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 3 79,622,791 - 79,647,402 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 79,613,171 - 79,646,698 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 86,319,497 - 86,354,972 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 75,144,314 - 75,178,964 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 75,041,014 - 75,074,718 (+) NCBI Celera 3 75,973,609 - 76,009,281 (+) NCBI Celera Cytogenetic Map 3 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Agbl2 Rat 1,2-dichloroethane increases expression ISO Agbl2 (Mus musculus) 6480464 ethylene dichloride results in increased expression of AGBL2 mRNA CTD PMID:28960355 Agbl2 Rat 1,2-dimethylhydrazine decreases expression ISO Agbl2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of AGBL2 mRNA CTD PMID:22206623 Agbl2 Rat 17beta-estradiol multiple interactions ISO AGBL2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of AGBL2 mRNA CTD PMID:30165855 Agbl2 Rat 17beta-estradiol decreases expression ISO AGBL2 (Homo sapiens) 6480464 Estradiol results in decreased expression of AGBL2 mRNA CTD PMID:31614463 Agbl2 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Agbl2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Agbl2 Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Agbl2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Agbl2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Agbl2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AGBL2 mRNA CTD PMID:21570461 Agbl2 Rat 4,4'-sulfonyldiphenol decreases expression ISO AGBL2 (Homo sapiens) 6480464 bisphenol S results in decreased expression of AGBL2 mRNA CTD PMID:30616060 Agbl2 Rat 4,4'-sulfonyldiphenol affects methylation ISO Agbl2 (Mus musculus) 6480464 bisphenol S affects the methylation of AGBL2 gene CTD PMID:31683443 Agbl2 Rat 4,4'-sulfonyldiphenol increases expression ISO Agbl2 (Mus musculus) 6480464 bisphenol S results in increased expression of AGBL2 mRNA CTD PMID:30951980 Agbl2 Rat aflatoxin B1 decreases expression ISO AGBL2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of AGBL2 mRNA CTD PMID:22100608 Agbl2 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AGBL2 mRNA CTD PMID:35163327 Agbl2 Rat aristolochic acid A increases expression ISO AGBL2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of AGBL2 mRNA CTD PMID:33212167 Agbl2 Rat benzo[a]pyrene increases expression ISO Agbl2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of AGBL2 mRNA CTD PMID:27195522 Agbl2 Rat benzo[a]pyrene affects methylation ISO AGBL2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AGBL2 exon CTD PMID:27901495 Agbl2 Rat benzo[a]pyrene decreases methylation ISO AGBL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of AGBL2 promoter CTD PMID:27901495 Agbl2 Rat benzo[a]pyrene decreases methylation ISO Agbl2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of AGBL2 exon and Benzo(a)pyrene results in decreased methylation of AGBL2 intron CTD PMID:27901495 Agbl2 Rat benzo[a]pyrene multiple interactions ISO Agbl2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA CTD PMID:27858113 Agbl2 Rat benzo[b]fluoranthene multiple interactions ISO Agbl2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA CTD PMID:27858113 Agbl2 Rat beta-lapachone decreases expression ISO AGBL2 (Homo sapiens) 6480464 beta-lapachone results in decreased expression of AGBL2 mRNA CTD PMID:38218311 Agbl2 Rat bis(2-ethylhexyl) phthalate increases expression ISO Agbl2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of AGBL2 mRNA CTD PMID:34319233 Agbl2 Rat bisphenol A decreases expression ISO Agbl2 (Mus musculus) 6480464 bisphenol A results in decreased expression of AGBL2 mRNA CTD PMID:26063408 Agbl2 Rat bisphenol A increases expression ISO Agbl2 (Mus musculus) 6480464 bisphenol A results in increased expression of AGBL2 mRNA CTD PMID:30951980 Agbl2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AGBL2 mRNA CTD PMID:25181051 Agbl2 Rat bisphenol F increases expression ISO Agbl2 (Mus musculus) 6480464 bisphenol F results in increased expression of AGBL2 mRNA CTD PMID:30951980 Agbl2 Rat butanal decreases expression ISO AGBL2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of AGBL2 mRNA CTD PMID:26079696 Agbl2 Rat caffeine decreases phosphorylation ISO AGBL2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of AGBL2 protein CTD PMID:35688186 Agbl2 Rat carbon nanotube decreases expression ISO Agbl2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Agbl2 Rat chrysene multiple interactions ISO Agbl2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA CTD PMID:27858113 Agbl2 Rat cisplatin increases expression ISO AGBL2 (Homo sapiens) 6480464 Cisplatin results in increased expression of AGBL2 mRNA CTD PMID:27392435 Agbl2 Rat crocidolite asbestos decreases expression ISO Agbl2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of AGBL2 mRNA CTD PMID:29279043 Agbl2 Rat cyclosporin A decreases expression ISO AGBL2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of AGBL2 mRNA CTD PMID:20106945 Agbl2 Rat dorsomorphin multiple interactions ISO AGBL2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Agbl2 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of AGBL2 mRNA CTD PMID:29391264 Agbl2 Rat epoxiconazole increases expression ISO Agbl2 (Mus musculus) 6480464 epoxiconazole results in increased expression of AGBL2 mRNA CTD PMID:35436446 Agbl2 Rat FR900359 increases phosphorylation ISO AGBL2 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of AGBL2 protein CTD PMID:37730182 Agbl2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of AGBL2 gene CTD PMID:35440735 Agbl2 Rat methylmercury chloride decreases expression ISO AGBL2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of AGBL2 mRNA CTD PMID:28001369 Agbl2 Rat ozone multiple interactions ISO Agbl2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AGBL2 mRNA CTD PMID:34911549 Agbl2 Rat paracetamol increases expression ISO AGBL2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of AGBL2 mRNA CTD PMID:22230336 Agbl2 Rat paracetamol decreases expression ISO AGBL2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of AGBL2 mRNA CTD PMID:29067470 Agbl2 Rat PCB138 multiple interactions ISO Agbl2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Agbl2 Rat perfluorooctane-1-sulfonic acid decreases expression ISO AGBL2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of AGBL2 mRNA CTD PMID:27153767 Agbl2 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AGBL2 mRNA CTD PMID:35163327 Agbl2 Rat phenylmercury acetate decreases expression ISO AGBL2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of AGBL2 mRNA CTD PMID:26272509 Agbl2 Rat phenylmercury acetate multiple interactions ISO AGBL2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGBL2 mRNA CTD PMID:27188386 Agbl2 Rat potassium dichromate decreases expression ISO Agbl2 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of AGBL2 mRNA CTD PMID:23608068 Agbl2 Rat quercetin increases expression ISO AGBL2 (Homo sapiens) 6480464 Quercetin results in increased expression of AGBL2 mRNA CTD PMID:21632981 Agbl2 Rat SB 431542 multiple interactions ISO AGBL2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Agbl2 Rat sodium arsenite decreases expression ISO AGBL2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of AGBL2 mRNA CTD PMID:29301061 Agbl2 Rat testosterone decreases expression ISO AGBL2 (Homo sapiens) 6480464 Testosterone results in decreased expression of AGBL2 mRNA CTD PMID:33359661 Agbl2 Rat tetraphene increases expression ISO Agbl2 (Mus musculus) 6480464 benz(a)anthracene results in increased expression of AGBL2 mRNA CTD PMID:26377693 Agbl2 Rat tetraphene multiple interactions ISO Agbl2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA CTD PMID:27858113 Agbl2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AGBL2 mRNA CTD PMID:34492290 Agbl2 Rat titanium dioxide decreases expression ISO Agbl2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of AGBL2 mRNA CTD PMID:23557971 and PMID:35295148 Agbl2 Rat titanium dioxide decreases methylation ISO Agbl2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of AGBL2 gene CTD PMID:35295148 Agbl2 Rat titanium dioxide increases expression ISO Agbl2 (Mus musculus) 6480464 titanium dioxide results in increased expression of AGBL2 mRNA CTD PMID:29264374 Agbl2 Rat trichostatin A decreases expression ISO AGBL2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of AGBL2 mRNA CTD PMID:24935251 and PMID:26272509 Agbl2 Rat trichostatin A multiple interactions ISO AGBL2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGBL2 mRNA CTD PMID:27188386 Agbl2 Rat triphenyl phosphate affects expression ISO AGBL2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of AGBL2 mRNA CTD PMID:37042841 Agbl2 Rat triptonide increases expression ISO Agbl2 (Mus musculus) 6480464 triptonide results in increased expression of AGBL2 mRNA CTD PMID:33045310 Agbl2 Rat valproic acid decreases expression ISO AGBL2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AGBL2 mRNA CTD PMID:23179753 more ... Agbl2 Rat valproic acid multiple interactions ISO AGBL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGBL2 mRNA CTD PMID:27188386
1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 4,4'-sulfonyldiphenol (ISO) aflatoxin B1 (ISO) alpha-Zearalanol (EXP) aristolochic acid A (ISO) benzo[a]pyrene (ISO) benzo[b]fluoranthene (ISO) beta-lapachone (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) butanal (ISO) caffeine (ISO) carbon nanotube (ISO) chrysene (ISO) cisplatin (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) dorsomorphin (ISO) endosulfan (EXP) epoxiconazole (ISO) FR900359 (ISO) methoxychlor (EXP) methylmercury chloride (ISO) ozone (ISO) paracetamol (ISO) PCB138 (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) phenylmercury acetate (ISO) potassium dichromate (ISO) quercetin (ISO) SB 431542 (ISO) sodium arsenite (ISO) testosterone (ISO) tetraphene (ISO) thioacetamide (EXP) titanium dioxide (ISO) trichostatin A (ISO) triphenyl phosphate (ISO) triptonide (ISO) valproic acid (ISO)
Agbl2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 97,220,654 - 97,255,905 (+) NCBI GRCr8 mRatBN7.2 3 76,764,893 - 76,800,071 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 76,764,238 - 76,800,214 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 3 79,622,791 - 79,647,402 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 79,613,171 - 79,646,698 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 86,319,497 - 86,354,972 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 75,144,314 - 75,178,964 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 75,041,014 - 75,074,718 (+) NCBI Celera 3 75,973,609 - 76,009,281 (+) NCBI Celera Cytogenetic Map 3 q24 NCBI
AGBL2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 47,659,591 - 47,715,369 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 47,659,591 - 47,715,389 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 47,681,143 - 47,736,921 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 47,637,719 - 47,692,878 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 11 47,828,422 - 47,883,671 (-) NCBI Celera Cytogenetic Map 11 p11.2 NCBI HuRef 11 47,386,826 - 47,442,523 (-) NCBI HuRef CHM1_1 11 47,680,423 - 47,736,178 (-) NCBI CHM1_1 T2T-CHM13v2.0 11 47,824,574 - 47,880,377 (-) NCBI T2T-CHM13v2.0
Agbl2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 90,613,029 - 90,664,781 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 90,613,071 - 90,664,781 (+) Ensembl GRCm39 Ensembl GRCm38 2 90,782,685 - 90,834,437 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 90,782,727 - 90,834,437 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 90,622,901 - 90,656,388 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 90,583,566 - 90,635,276 (+) NCBI MGSCv36 mm8 Celera 2 92,167,447 - 92,201,166 (+) NCBI Celera Cytogenetic Map 2 E1 NCBI cM Map 2 50.37 NCBI
AGBL2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 9 49,868,323 - 49,924,290 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 11 49,888,052 - 49,944,878 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 11 47,613,564 - 47,669,809 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 11 48,163,160 - 48,218,611 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 11 48,163,742 - 48,217,869 (-) Ensembl panpan1.1 panPan2
AGBL2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 18 41,960,085 - 42,003,399 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 18 41,960,912 - 42,002,255 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 18 40,691,514 - 40,734,468 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 18 42,616,043 - 42,658,721 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 18 42,616,217 - 42,658,118 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 18 42,104,209 - 42,141,564 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 18 41,657,442 - 41,700,277 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 18 42,387,511 - 42,430,423 (+) NCBI UU_Cfam_GSD_1.0
Agbl2 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404947 19,452,568 - 19,509,105 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936562 1,564,607 - 1,593,273 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936562 1,563,607 - 1,598,451 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
AGBL2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 2 14,933,197 - 14,972,397 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 2 14,933,188 - 14,971,416 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 2 16,111,605 - 16,148,424 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
AGBL2 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 1 17,602,673 - 17,679,431 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 1 17,603,105 - 17,676,105 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666038 114,892,707 - 114,994,829 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Agbl2
.
Predicted Target Of
Count of predictions: 510 Count of miRNA genes: 254 Interacting mature miRNAs: 305 Transcripts: ENSRNOT00000011467, ENSRNOT00000038696, ENSRNOT00000066828, ENSRNOT00000067067, ENSRNOT00000067769 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1300178 Hrtrt4 Heart rate QTL 4 3.74 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 43827364 90905114 Rat 61377 Edpm3 Estrogen-dependent pituitary mass QTL 3 7.05 0.038 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 53184692 89878207 Rat 2301414 Kidm37 Kidney mass QTL 37 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 70653097 121056321 Rat 1582238 Bw68 Body weight QTL 68 3.2 0.0064 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 1331795 Rf30 Renal function QTL 30 3.708 urine potassium amount (VT:0010539) urine potassium level (CMO:0000128) 3 39454637 89115240 Rat 1582239 Epfw1 Epididymal fat weight QTL 1 4.5 0.0006 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 3 53184593 115665732 Rat 70216 Cm14 Cardiac mass QTL 14 2.1 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 31172320 163586636 Rat 1354589 Bw31 Body weight QTL 31 3.3 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 78196190 Rat 2298542 Neuinf11 Neuroinflammation QTL 11 3.9 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 3 15005422 76927699 Rat 2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 3 47233211 147415807 Rat 1358362 Srcrt2 Stress Responsive Cort QTL 2 2.78 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 38192233 133483320 Rat 737818 Hcar12 Hepatocarcinoma resistance QTL 12 2.6 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 3 29463235 118376539 Rat 1582218 Bw74 Body weight QTL 74 3.9 0.0021 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 1331777 Bw24 Body weight QTL 24 3.503 body mass (VT:0001259) body weight (CMO:0000012) 3 39454637 89115240 Rat 1582221 Kidm30 Kidney mass QTL 30 3.5 0.0008 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 3 64655305 115665732 Rat 1581568 Rf53 Renal function QTL 53 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 3 56395968 161299569 Rat 1582210 Bw71 Body weight QTL 71 3.3 0.0012 body mass (VT:0001259) body weight (CMO:0000012) 3 64655305 115665732 Rat 1300111 Rf12 Renal function QTL 12 3.78 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 3 61017749 121056321 Rat 724523 Tsu1 Thymus enlargement suppressive QTL 1 3.84 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 3 50437504 115638231 Rat 1600376 Arunc5 Aerobic running capacity QTL 5 0.21 exercise endurance trait (VT:0002332) maximum distance run on treadmill (CMO:0001406) 3 73376539 118376539 Rat 8662816 Vetf4 Vascular elastic tissue fragility QTL 4 4 renal artery integrity trait (VT:0010642) number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563) 3 59242096 157323038 Rat 1559282 Emca5 Estrogen-induced mammary cancer QTL 5 3.9 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 3 43827364 169034231 Rat 1581503 Cm58 Cardiac mass QTL 58 2.7 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 43827364 121056321 Rat 2292613 Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat 731180 Bp152 Blood pressure QTL 152 0.03 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 53781112 91609953 Rat 738019 Anxrr10 Anxiety related response QTL 10 3.9 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 3 38517803 83517803 Rat 631200 Cm25 Cardiac mass QTL 25 4.8 0.0001 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 3 61134348 89115068 Rat 61419 Cia11 Collagen induced arthritis QTL 11 5.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 3 30356773 98535386 Rat 12879848 Bw181 Body weght QTL 181 0.015 body mass (VT:0001259) body weight (CMO:0000012) 3 70348525 121056321 Rat 1358905 Hrtrt17 Heart rate QTL 17 5.9 0.000014 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 10861912 89878372 Rat 2301971 Cm71 Cardiac mass QTL 71 4.63 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 3 41874578 155617519 Rat 1358885 Bp251 Blood pressure QTL 251 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 1354597 Kidm13 Kidney mass QTL 13 2.9 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 3 41874578 104104347 Rat 2301970 Bw81 Body weight QTL 81 5.19 body mass (VT:0001259) body weight (CMO:0000012) 3 41874578 155617519 Rat 2290452 Scl56 Serum cholesterol level QTL 56 2.26 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 3 1 91609953 Rat 1354604 Bw36 Body weight QTL 36 2.9 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 104104347 Rat 631665 Bw8 Body weight QTL 8 5.5 body mass (VT:0001259) body weight (CMO:0000012) 3 50437042 119183768 Rat 1358888 Bp264 Blood pressure QTL 264 4.43 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 1358186 Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat
BG372703
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 3 97,219,208 - 97,219,366 (+) Marker Load Pipeline mRatBN7.2 3 76,763,369 - 76,763,527 (+) MAPPER mRatBN7.2 Rnor_6.0 3 79,610,413 - 79,610,570 NCBI Rnor6.0 Rnor_5.0 3 86,317,906 - 86,318,063 UniSTS Rnor5.0 RGSC_v3.4 3 75,141,940 - 75,142,097 UniSTS RGSC3.4 Celera 3 75,972,533 - 75,972,690 UniSTS Cytogenetic Map 3 q24 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
9
49
113
87
86
55
25
55
6
207
90
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000011467 ⟹ ENSRNOP00000011467
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 76,764,238 - 76,797,348 (+) Ensembl Rnor_6.0 Ensembl 3 79,613,171 - 79,646,698 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000109326 ⟹ ENSRNOP00000084139
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 76,764,238 - 76,800,214 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000112284 ⟹ ENSRNOP00000080118
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 76,766,128 - 76,800,214 (+) Ensembl
RefSeq Acc Id:
XM_039106792 ⟹ XP_038962720
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,221,200 - 97,255,905 (+) NCBI mRatBN7.2 3 76,766,128 - 76,800,071 (+) NCBI
RefSeq Acc Id:
XM_039106793 ⟹ XP_038962721
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,221,200 - 97,255,905 (+) NCBI mRatBN7.2 3 76,764,959 - 76,800,071 (+) NCBI
RefSeq Acc Id:
XM_039106794 ⟹ XP_038962722
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,220,654 - 97,255,905 (+) NCBI mRatBN7.2 3 76,764,893 - 76,800,071 (+) NCBI
RefSeq Acc Id:
XM_039106799 ⟹ XP_038962727
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,221,200 - 97,249,874 (+) NCBI mRatBN7.2 3 76,766,128 - 76,794,040 (+) NCBI
RefSeq Acc Id:
XM_063284884 ⟹ XP_063140954
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,221,200 - 97,255,905 (+) NCBI
RefSeq Acc Id:
XM_063284885 ⟹ XP_063140955
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,220,654 - 97,255,905 (+) NCBI
RefSeq Acc Id:
XM_063284887 ⟹ XP_063140957
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,221,200 - 97,255,905 (+) NCBI
RefSeq Acc Id:
XM_063284888 ⟹ XP_063140958
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,220,654 - 97,255,905 (+) NCBI
RefSeq Acc Id:
XM_063284889 ⟹ XP_063140959
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,220,773 - 97,255,905 (+) NCBI
RefSeq Acc Id:
XM_063284890 ⟹ XP_063140960
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,220,654 - 97,249,874 (+) NCBI
RefSeq Acc Id:
XM_063284891 ⟹ XP_063140961
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,221,200 - 97,249,874 (+) NCBI
RefSeq Acc Id:
XM_063284892 ⟹ XP_063140962
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 97,220,654 - 97,249,874 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000011467 ⟸ ENSRNOT00000011467
RefSeq Acc Id:
XP_038962722 ⟸ XM_039106794
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I5ZPZ4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038962721 ⟸ XM_039106793
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I5ZPZ4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038962720 ⟸ XM_039106792
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I5ZPZ4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038962727 ⟸ XM_039106799
- Peptide Label:
isoform X6
- UniProtKB:
D4A3W7 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000080118 ⟸ ENSRNOT00000112284
Ensembl Acc Id:
ENSRNOP00000084139 ⟸ ENSRNOT00000109326
RefSeq Acc Id:
XP_063140955 ⟸ XM_063284885
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_063140958 ⟸ XM_063284888
- Peptide Label:
isoform X4
- UniProtKB:
A0A8I5ZPZ4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063140960 ⟸ XM_063284890
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_063140962 ⟸ XM_063284892
- Peptide Label:
isoform X7
RefSeq Acc Id:
XP_063140959 ⟸ XM_063284889
- Peptide Label:
isoform X5
- UniProtKB:
A0A8I5ZPZ4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063140954 ⟸ XM_063284884
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I5ZX61 (UniProtKB/TrEMBL), A0A8I5ZPZ4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063140957 ⟸ XM_063284887
- Peptide Label:
isoform X4
- UniProtKB:
A0A8I5ZPZ4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063140961 ⟸ XM_063284891
- Peptide Label:
isoform X7
- UniProtKB:
D4A3W7 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Agbl2
AGBL carboxypeptidase 2
LOC103690183
cytosolic carboxypeptidase 2-like
Data merged from RGD:9134955
737654 PROVISIONAL
2021-02-18
Agbl2
AGBL carboxypeptidase 2
Agbl2
ATP/GTP binding protein-like 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2014-08-25
LOC103690183
cytosolic carboxypeptidase 2-like
Symbol and Name status set to provisional
70820 PROVISIONAL
2008-04-30
Agbl2
ATP/GTP binding protein-like 2
Agbl2_predicted
ATP/GTP binding protein-like 2 (predicted)
'predicted' is removed
2292626 APPROVED
2006-03-30
Agbl2_predicted
ATP/GTP binding protein-like 2 (predicted)
RGD1306827_predicted
similar to CG32627-PB (predicted)
Symbol and Name updated
1299863 APPROVED
2005-01-20
RGD1306827_predicted
similar to CG32627-PB (predicted)
LOC366124_predicted
Symbol and Name status set to approved
1331353 APPROVED
2005-01-12
LOC366124_predicted
similar to CG32627-PB (predicted)
Symbol and Name status set to provisional
70820 PROVISIONAL
